PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Developing microbial cell factories by employing synthetic small regulatory RNAs

A new metabolic engineering tool that allows fine control of gene expression level by employing synthetic small regulatory RNAs was developed to efficiently construct microbial cell factories producing desired chemicals and materials

2013-01-21
(Press-News.org) Biotechnologists have been working hard to address the climate change and limited fossil resource issues through the development of sustainable processes for the production of chemicals, fuels and materials from renewable non-food biomass. One promising sustainable technology is the use of microbial cell factories for the efficient production of desired chemicals and materials. When microorganisms are isolated from nature, the performance in producing our desired product is rather poor. Metabolic engineering is performed to improve the metabolic and cellular characteristics to achieve enhanced production of desired product at high yield and productivity. Since the performance of microbial cell factory is very important in lowering the overall production cost of the bioprocess, many different strategies and tools have been developed for the metabolic engineering of microorganisms.

One of the big challenges in metabolic engineering is to find the best platform organism and to find those genes to be engineered so as to maximize the production efficiency of the desired chemical. Even Escherichia coli, the most widely utilized simple microorganism, has thousands of genes, the expression of which is highly regulated and interconnected to finely control cellular and metabolic activities. Thus, the complexity of cellular genetic interactions is beyond our intuition and thus it is very difficult to find effective target genes to engineer. Together with gene amplification strategy, gene knockout strategy has been an essential tool in metabolic engineering to redirect the pathway fluxes toward our desired product formation. However, experiment to engineer many genes can be rather difficult due to the time and effort required; for example, gene deletion experiment can take a few weeks depending on the microorganisms. Furthermore, as certain genes are essential or play important roles for the survival of a microorganism, gene knockout experiments cannot be performed. Even worse, there are many different microbial strains one can employ. There are more than 50 different E. coli strains that metabolic engineer can consider to use. Since gene knockout experiment is hard-coded (that is, one should repeat the gene knockout experiments for each strain), the result cannot be easily transferred from one strain to another.

A paper published in Nature Biotechnology online today addresses this issue and suggests a new strategy for identifying gene targets to be knocked out or knocked down through the use of synthetic small RNA. A Korean research team led by Distinguished Professor Sang Yup Lee at the Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), reported that synthetic small RNA can be employed for finely controlling the expression levels of multiple genes at the translation level. Already well-known for their systems metabolic engineering strategies, Professor Lee's team added one more strategy to efficiently develop microbial cell factories for the production of chemicals and materials.

Gene expression works like this: the hard-coded blueprint (DNA) is transcribed into messenger RNA (mRNA), and the coding information in mRNA is read to produce protein by ribosomes. Conventional genetic engineering approaches have often targeted modification of the blueprint itself (DNA) to alter organism's physiological characteristics. Again, engineering the blueprint itself takes much time and effort, and in addition, the results obtained cannot be transferred to another organism without repeating the whole set of experiments. This is why Professor Lee and his colleagues aimed at controlling the gene expression level at the translation stage through the use of synthetic small RNA. They created novel RNAs that can regulate the translation of multiple messenger RNAs (mRNA), and consequently varying the expression levels of multiple genes at the same time. Briefly, synthetic regulatory RNAs interrupt gene expression process from DNA to protein by destroying the messenger RNAs to different yet controllable extents. The advantages of taking this strategy of employing synthetic small regulatory RNAs include simple, easy and high-throughput identification of gene knockout or knockdown targets, fine control of gene expression levels, transferability to many different host strains, and possibility of identifying those gene targets that are essential.

As proof-of-concept demonstration of the usefulness of this strategy, Professor Lee and his colleagues applied it to develop engineered E. coli strains capable of producing an aromatic amino acid tyrosine, which is used for stress symptom relief, food supplements, and precursor for many drugs. They examined a large number of genes in multiple E. coli strains, and developed a highly efficient tyrosine producer. Also, they were able to show that this strategy can be employed to an already metabolically engineered E. coli strain for further improvement by demonstrating the development of highly efficient producer of cadaverine, an important platform chemical for nylon in the chemical industry.

This new strategy, being simple yet very powerful for systems metabolic engineering, is thus expected to facilitate the efficient development of microbial cell factories capable of producing chemicals, fuels and materials from renewable biomass.

###Source:

Dokyun Na, Seung Min Yoo, Hannah Chung, Hyegwon Park, Jin Hwan Park, and Sang Yup Lee, "Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs", Nature Biotechnology, doi:10.1038/nbt.2461 (2013)

This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556) and the Intelligent Synthetic Biology Center through the Global Frontier Project (2011-0031963) of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea.

Further Contacts: Dr. Sang Yup Lee, Distinguished Professor, KAIST, Daejeon, Korea (leesy@kaist.ac.kr, +82-42-350-3930)


ELSE PRESS RELEASES FROM THIS DATE:

Genetic basis of high-risk childhood cancer points to possible new drug treatment strategy

2013-01-21
(MEMPHIS, Tenn. – January 20, 2013) Research led by St. Jude Children's Research Hospital scientists has identified a possible lead in treatment of two childhood leukemia subtypes known for their dramatic loss of chromosomes and poor treatment outcomes. The findings also provide the first evidence of the genetic basis for this high-risk leukemia, which is known as hypodiploid acute lymphoblastic leukemia (ALL). Normal human cells have 46 chromosomes, half from each parent, but hypodiploid ALL is characterized by fewer than 44 chromosomes. Chromosomes are highly condensed ...

La Jolla Institute identifies molecular switch enabling immune cells to better fight disease

2013-01-21
SAN DIEGO – (January 20th, 2013) A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells. The finding, made in collaboration with researchers from the RIKEN Institute in Japan, could enable the development of more potent drugs for AIDS, cancer and many other diseases based on using this mechanism to trigger larger armies of killer T cells against ...

Tucson Psychologist Offering Treatment for Sex Addiction

2013-01-21
Tucson Therapist, Dr. Shannon Sticken, announces that she is offering therapy and counseling for individuals and couples who are working to overcome problems with sex addiction. Dr. Sticken is a Licensed Psychologist and Certified Sex Addiction Therapist who has extensive work experience and training to help clients rebuild their lives after sex addiction. "When many of my clients come into treatment, they are trying to figure out how to not only control their behavior, but also to build or rebuild trust and intimacy," says Sticken. This is what creates the ...

Luminous Life Frames Celebrates Life's Memories with Exquisite Photo Frames

2013-01-21
A picture is worth a thousand words and a stylish picture frame only adds to that value. Luminous Life Frames launches their exquisite photo frames giving families,businesses and friends a alternative to the typical picture frame. Luminous Life is creation of a line of stunning backlit photo frames designed to celebrate the great moments of life. Luminous Life Frames utilizes your treasured photos to create heirloom "memory frames" for celebrations including weddings, Bar/Bat Mitzvah's, birthdays, graduations, family reunions, and anniversaries. Luminous Life ...

Revolutionary Golf Aid Given USGA Approval Before Exhibiting at 2013 PGA Show

2013-01-21
The Eagle Claw, a revolutionary swing support golf grip aid exhibiting at the 2013 PGA Show this month in Florida, will proudly display their most recent achievement: USGA approval under the section "Equipment Permitted Conditionally for Medical Reasons" which was granted earlier this month. The Eagle Claw was conceived over 10 years ago when inventor Gerald Basden strained his thumb during a golf round. The usually debilitating ailment led to Gerald building a prototype that would enable him to continue to play golf whilst the injury healed without loss to ...

"Shamanic Art of Reciprocal Exchange" on January 22 "Why Shamanism Now?" with Host Christina Pratt

2013-01-21
Streaming live on the Co-Creator Radio Network (www.co-creatornetwork.com) on Tuesday, January 22, at 11 a.m. Pacific time/2 p.m. Eastern time, on her show "Why Shamanism Now?: A Practical Path to Authenticity," shaman and founder of the Last Mask Center for Shamanic Healing Christina Pratt tells listeners that if the New World is to be different than the one before, then we must learn to ally our minds with paradox. We must see the deeper truth that the nature of our world—and our selves included—is the living expression of complementary dualism in which two ...

Michael H. Lord Gallery Announces New Exhibition: Artist Betty Gold

2013-01-21
The Michael Lord Gallery is pleased to announce the exhibition: Betty Gold: New Maquettes and Paintings. The public is invited to attend the opening artist reception on Friday, February 1, from 6 to 8 pm. The exhibition continues through February 28. Betty Gold was born in 1935 in Austin, Texas. After completing her studies at the University of Texas, she entered the tutelage and apprenticeship of sculptor Octavio Medillan in Dallas, Texas. As art writer Steven Biller notes, "Gold is a former beauty pageant winner with jet black hair and a native Texas twang. She ...

One Thirteen Luxury Home Decor Meets Your Transitional Furniture Needs

2013-01-21
One Thirteen Luxury Home Decor has improved the online, home decor market through its website http://www.onethirteen.com. This simple and accessible online store has made it easier to purchase transitional and other styles of furniture than previously imagined. The site allows registered users to make their selections through timed offers, giving the customer access to a regular selection of new products. By so doing they eliminate the time often associated with gaining access to a new stock of transitional furniture. This ease of access is also seen in the customer account ...

FDA Requires Lower Doses of Sleeping Drugs, While Natural Insomnia Remedies Exist

2013-01-21
The U.S. Food and Drug Administration has announced it is requiring users of the insomnia drug Ambien and its generic counterparts (all drugs containing the active ingredient zolpidem), to take a lower recommended dose of these medications. They are particularly aiming this toward women, as the drug stays in their system much longer than with men. Women at the time of menopause frequently have sleep problems and insomnia, and some may turn to sleep medications. Ellis Unger, M.D., director of the Office of Drug Evaluation in the FDA's Center for Drug Evaluation and Research ...

Integrated Audio Video Poised for Growth as New Project Managers Join the Team

2013-01-21
Brian Giordano, President of Integrated Audio Video at Southpoint, has announced that David Steffens has joined the team as a Senior Project Manager, and Garrett Seybert has been hired as a Level 1 Project Manager. Originally from Troy, Michigan, David Steffens has over 20 years of experience in electronics working for companies including: Tweeter in North Carolina, NOW Audio Video in North Carolina and Tennessee, Media Systems in Boston and Palm Beach, and Rising Sounds in Florida. As Senior Project Manager at Integrated Audio Video, Steffens will be responsible for ...

LAST 30 PRESS RELEASES:

Impact of pollutants on pollinators, and how neural circuits adapt to temperature changes

Researchers seek to improve advanced pain management using AI for drug discovery

‘Neutron Nexus’ brings universities, ORNL together to advance science

Early release from NEJM Evidence

UMass Amherst astronomer leads science team helping to develop billion-dollar NASA satellite mission concept

Cultivating global engagement in bioengineering education to train students skills in biomedical device design and innovation

Life on Earth was more diverse than classical theory suggests 800 million years ago, a Brazilian study shows

International clean energy initiative launches global biomass resource assessment

How much do avoidable deaths impact the economy?

Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans

New therapeutic target for cardiac arrhythmias emerges

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

Moffitt study unveils the role of gamma-delta T cells in cancer immunology

Drier winter habitat impacts songbirds’ ability to survive migration

Donors enable 445 TPDA awards to Neuroscience 2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

Are auditory magic tricks possible for a blind audience?

Research points to potential new treatment for aggressive prostate cancer subtype

Studies examine growing US mental health safety net

Social risk factor domains and preventive care services in US adults

Online medication abortion direct-to-patient fulfillment before and after the Dobbs v Jackson decision

Black, Hispanic, and American Indian adolescents likelier than white adolescents to be tested for drugs, alcohol at pediatric trauma centers

Pterosaurs needed feet on the ground to become giants

Scientists uncover auditory “sixth sense” in geckos

Almost half of persons who inject drugs (PWID) with endocarditis will die within five years; women are disproportionately affected

Experimental blood test improves early detection of pancreatic cancer

Groundbreaking wastewater treatment research led by Oxford Brookes targets global challenge of toxic ‘forever chemicals’

Jefferson Health awarded $2.4 million in PCORI funding

Cilta-cel found highly effective in first real-world study

Unleashing the power of generative AI on smart collaborative innovation network platform to empower research and technology innovation

[Press-News.org] Developing microbial cell factories by employing synthetic small regulatory RNAs
A new metabolic engineering tool that allows fine control of gene expression level by employing synthetic small regulatory RNAs was developed to efficiently construct microbial cell factories producing desired chemicals and materials